Tuberculosis Vaccine Market Opportunity Analysis, 2018-2026
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1602
Tuberculosis Vaccine Market Dynamics
Tuberculosis account for the highest amount of death caused due to infectious disease across the globe. According to the World Health Organization (WHO) factsheet 2018 on TB, 10.4 million people fell ill with TB in 2016 and 1.7 million people with TB died in the same year. More than 95% of TB deaths occur in low- and middle-income economies. Deaths caused due to TB also includes death of 0.4 million people infected with HIV. Such high number of patients across the world confirms the enormity of disease and urgent requirements for vaccines worldwide. Therefore, the launch of tuberculosis vaccine would gain significant revenue and in turn, would propel the market growth. According to a global report on tuberculosis vaccine in 2018, TB costs around US$ 21 billion annually to global economy.
Another important impetus to tuberculosis vaccine market would be current complex drug regime and resistance TB has created to this drug regime. TB patient has to take more than 2-3 drugs for prolonged time period of 6 months in order to suppress the infection. Often this results in the poor patient compliance and eventually leads to drug resistance incidence which further deteriorate the TB. According to WHO, there were nearly 600,000 new cases with resistance to rifampicin antibiotic, which was the most effective first-line drug in 2017, of which around 490,000 had MDR-TB globally. If effective steps won’t be taken by 2050, MDR-TB alone could cost the world US$ 16.7 trillion as per global report on tuberculosis vaccine 2018. Drug toxicity due to high daily dose and prolonged treatment is another concern with current TB drugs. Although the cost of TB drug is not much of concern in developing economies due to government support and free medication, it is a matter of concern in developed countries such as the U.S. and Europe. Increased recognition of TB’s fatality by intergovernmental organization and national government would prosper funding for TB vaccine research. Increased research and development activities for development of vaccine against TB by companies and intergovernmental organizations is expected to boost growth of tuberculosis vaccine market. For instance, Aeras is an NGO, which supports TB vaccine development and has helped develop 9 TB vaccine candidates and conducted over 35 Phase 1-2b clinical trials.
Tuberculosis Vaccine Market - Regional Insights
TB is most prevalent in middle and low income economies in Asia Pacific and Africa and therefore, these regions would represent greatest opportunity for the potential TB vaccine. According to the World Health Organization factsheet 2018 on TB, countries such as India, China, Indonesia, Philippines, Pakistan, Nigeria, and South Africa account for around 64% of the total TB deaths. Another risk factor for these regions is the high number of HIV positive population living in this region. Around 40% of deaths among HIV-positive people were due to TB in 2016 as per WHO.
Tuberculosis vaccine could prove most beneficial for these regions and in turn, would drive growth of tuberculosis vaccine market. Government initiatives and international support to curb TB incidence would speed up the vaccine development and also would support access for such vaccines. India, which accounts for half a million global TB deaths has launched National Strategic Plan (NSP) for TB Elimination 2017-2025 to combat TB. India also formed India TB Research Consortium to boost TB vaccine and medication research. Developed regions such as North America accounts for significant number of TB patients. According to the Centre for Disease Control, a total of 9,093 TB cases were reported in the U.S. in 2017. MDR-TB and XDR-TB accounted for approximately US$ 160,000 and US$ 513,000 respectively for treatment of each patient. Effective vaccine against TB would gain significant traction in countries such as the U.S.
Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/1602
Tuberculosis Vaccine Market - Competitive Landscape
Many companies and research institutes are taking efforts to develop tuberculosis vaccine to combat TB. There are fourteen TB vaccines under clinical trials, out of which one investigational candidate named Vaccae from China is in phase three whereas three are in late phase 2. Most of the researches are carried out in academic and research places, which eventually would be transferred to commercial companies for effective distribution and access. Companies are also improving current BCG vaccines, in order to target TB by bringing recombinant vaccine product.
Some of the key players in the tuberculosis vaccine market include GlaxoSmithKline, Sanofi Pasture, Longcom Enterprise Ltd, Biofabri, Valneva plc, and Archivel Farma S.L.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Vaccine Market Opportunity Analysis, 2018-2026 here
News-ID: 1171332 • Views: 293
More Releases from Coherent Market Insights
Protective Coatings Market | Akzo Nobel N.V., The Valspar Corporation and PPG In …
Coherent Market Insights, one of the leading market research firm has recently published a report.This report will provide data on the current and future trends of market, ongoing competition, key players share, market volume and value, etc. The key information covered in the report will help the existing as well as new entrants to get in-depth market knowledge and make appropriate business decisions for short term and long-term. The Protective
Antistatic Agents Market | Akzo Nobel N.V., 3M Company, BASF SE and Ampacet Corp …
Antistatic agents prevent or reduce accumulation of static electricity on surfaces. Fatty acid esters, quaternary ammonium compounds, alkylsulfonates, ethoxylated amines, and alkylphosphates are some of the widely used antistatic agents. Antistatic agent eliminates problems such as dust pick up, and electrical discharge This Antistatic Agents report consist of the basic overview of the market, including product definitions, classifications, new product launches, key developments and the industry chain structure of the overall
Pharmaceutical Pouch Market Revenue and Value Chain 2018-2026 | Coherent Market …
The Pharmaceutical Pouch report presents high-quality and wide-ranging research study with key factors that are expected to have a Major impact on the Pharmaceutical Pouch during the forecast period. The report present Key Market segments valued based on its growth rate and share.This report also provides an analysis of the impact of the COVID-19 pandemic on Industrial Labels Industry.The report explains the historical and current trends that are shaping
Thin Wall Packaging Market Value Share, Supply Demand 2020-2027 | Coherent Marke …
Thin wall packaging is a type of packaging, which utilizes thin and lightweight plastic. The use of lightweight plastics makes the production process cost efficient and time saving. The utilization of the resources efficiently at higher production rate helps the packaging companies in achieving higher cost efficiency. The Thin Wall Packaging report covers significant data related to the market driving forces that are predicted to have a huge impact on the
More Releases for Tuberculosis
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Tuberculosis Drugs Market Industry Forecast till 2024
Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, extensive awareness campaigns and initiatives by various governments to curb the menace is bearing fruit. Tuberculosis treatment helped prevent 49 million fatalities associated with the condition between 2000 and 2015. However, there are still some prominent diagnostic and treatment slits that continue. In 2015, approximately 6.1 million newly diagnosed tuberculosis cases were
Tuberculosis Diagnosis and Treatment Market
The Global Tuberculosis diagnosis and treatment market is relied upon to develop at a CAGR of 2.3 % amid 2017-2022. An irresistible illness caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis by and large influences the lungs yet can likewise influence different parts of the body. Inert tuberculosis is the sort of TB which don't have indications. Around 10% of inert contaminations advance to dynamic
Global Tuberculosis Diagnostics Sales Market Report 2018
The Global Tuberculosis Diagnostics Sales Market Report 2018 is a professional and in-depth study on the current state of the Tuberculosis Diagnostics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Tuberculosis Diagnostics Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This
Tuberculosis Testing Market | Analysis & Trends 2020
Key players in the Global Tuberculosis (TB) Testing Market, according to a report by Transparency Market Research, are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc. QIAGEN, Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., and Sanofi. Among them, the top players namely, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, and Hain Lifescience GmbH
Tuberculosis: A Neglected Pandemic
The German Center for Research and Innovation (GCRI), in cooperation with the Max Planck Florida Institute, will host a discussion on the treatments and challenges of tuberculosis on Thursday, March 31, from 7:00 to 9:00 p.m. The event will take place at the German House New York (871 United Nations Plaza, First Avenue, btw. 48th & 49th Streets). Tuberculosis, along with HIV/AIDS, is one of today’s deadliest threats. Killing one